SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000921895-23-002063
Filing Date
2023-08-23
Accepted
2023-08-23 16:47:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d13224004_08222023.htm SC 13D 399438
2 GROUP AGREEMENT ex991to13d13224004_08222023.htm EX-99.1 37775
3 POWERS OF ATTORNEY ex992to13d13224004_08222023.htm EX-99.2 15779
  Complete submission text file 0000921895-23-002063.txt   454626
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89959 | Film No.: 231198099
SIC: 2834 Pharmaceutical Preparations

Mailing Address CAMAC CAPITAL, LLC 350 PARK AVENUE, 13TH FLOOR NEW YORK NY 10022
Business Address CAMAC CAPITAL, LLC 350 PARK AVENUE, 13TH FLOOR NEW YORK NY 10022 914-629-8496
Camac Fund, LP (Filed by) CIK: 0001516478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D